2021-2022 Regular Session • US Congress Legislature
HB9011: Updated Drug Labeling for Patient Safety Act
Legislative Summary
To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information, and for other purposes.
Bill History
9/28/2022
Introduced in House
House of Representatives
9/28/2022
Referred to the House Committee on Energy and Commerce.
House of Representatives
9/29/2022
Referred to the Subcommittee on Health.
House of Representatives
Status Information
Current Status
Introduced(9/28/2022)
Chamber
House of Representatives
Committee
Subcommittee on Health(House of Representatives)
Sponsors
Democrat: 1
Primary Sponsor
Donald McEachin
Democrat